Antiproliferative Effects of Cynara cardunculus L. var. altilis (DC) Lipophilic Extracts

Patrícia A B Ramos1,2, Ângela R Guerra3,4, Olinda Guerreiro5,6

  • 1Centro de Biotecnologia Agrícola e Agro-Alimentar do Alentejo (CEBAL)/Instituto Politécnico de Beja (IPBeja), 7801-908 Beja, Portugal. patricia.ramos@cebal.pt.

Insights

Cardoon leaf extract and cynaropicrin show anticancer effects against triple-negative breast cancer (TNBC) cells. These natural compounds may offer a basis for new TNBC therapies.

Area of Science:

  • Phytochemistry
  • Oncology
  • Molecular Biology

Background:

  • *Cynara cardunculus* L. (cardoon) has traditional uses for liver disorders.
  • Cardoon exhibits potential anticancer properties, particularly against triple-negative breast cancer (TNBC).
  • Lipophilic extracts and specific compounds from cardoon warrant investigation for their efficacy against TNBC cell lines.

Purpose of the Study:

  • To evaluate the antiproliferative effects of cardoon leaf and floret extracts and their major compounds (cynaropicrin, taraxasteryl acetate) on MDA-MB-231 TNBC cells.
  • To investigate the molecular mechanisms underlying the observed antiproliferative activity, including effects on cell cycle regulation and signaling pathways.
  • To determine the potential of cardoon extracts and cynaropicrin as natural therapeutic agents for TNBC.

Main Methods:

  • Preparation and testing of lipophilic extracts from *C. cardunculus* L. var. *altilis* leaves and florets.
  • Assessment of antiproliferative activity using IC50 values against MDA-MB-231 cells.
  • Anchorage-independent growth assay to evaluate colony formation inhibition.
  • Spectrophotometric assay for caspase-3 activity and Western blotting for cell cycle and Akt pathway proteins.

Main Results:

  • Cardoon leaves extract demonstrated significantly higher antiproliferative activity (IC50 = 10.39 µg/mL) against MDA-MB-231 cells compared to florets extract (IC50 = 315.22 µg/mL).
  • Leaves extract and cynaropicrin inhibited colony formation of MDA-MB-231 cells (IC50 = 6.19 µg/mL for cynaropicrin).
  • Leaves extract increased caspase-3 activity, while both leaves extract and cynaropicrin induced G2/mitosis cell cycle arrest via p21 upregulation and altered CDK1/cyclin B1 expression, and downregulated phospho-Akt.

Conclusions:

  • Lipophilic extracts from cultivated cardoon leaves and the compound cynaropicrin possess significant antiproliferative effects against TNBC cells.
  • The observed effects are mediated through mechanisms including G2 cell cycle arrest and Akt signaling pathway modulation.
  • Cardoon leaf extract and cynaropicrin represent promising candidates for developing natural-based therapeutic strategies for TNBC.